Global Compound Management Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Sample Type (Chemical Compounds and Bio Samples), By End User, By Regional Outlook and Forecast, 2022 - 2028

Global Compound Management Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Sample Type (Chemical Compounds and Bio Samples), By End User, By Regional Outlook and Forecast, 2022 - 2028

The Global Compound Management Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 15.5% CAGR during the forecast period.

Compound management comprises maintaining the chemical libraries, which includes robotics for chemical retrieval and database updates of chemical information. It also includes restoring out-of-date chemicals and maintaining the quality of the storage environment. Compound Control is another name for compound management.

Compound Management provides the infrastructure and logistics that aid in managing research compounds. It aids in the development of new drugs, and entails the logistics of storing, preparing, and evaluating compounds for testing as well as dispensing them during the drug discovery process. To avoid significant ripple effects that could prevent the release of treatments that are feasible and effective, compound management must be handled properly and meticulously. Due to the impact of using the incorrect chemical for comparison, inaccurate compound concentrations, or testing.

Compound collection management is made simpler, sample integrity is guaranteed, and turnaround times for samples are sped up through automated storage options. Additionally, novel high-throughput screening methods are now supported by advancements brought about by new computerized sample management technology. Fully automated processes for assay plate preparation, molecular weighing and dissolution, and library maintenance greatly enhance drug discovery workflows by reducing labor-intensive and error-prone processes.

COVID-19 Impact Analysis

Despite the decrease in COVID-19 incidences, the importance of COVID-19 vaccinations has increased significantly. The demand for COVID-19 vaccinations is rising as a result of the concern that a new COVID-19 variation would emerge. As a result, numerous pharmaceutical companies are creating vaccines. This is probably going to increase demand for COVID-19 vaccine compound management. The majority of COVID-19 medications and vaccines were in development during the pandemic. However, according to the Pharma R & D annual assessment for 2022, the two main pharmaceuticals in development at the time were biotechnology and anticancer medications. Due to the increased demand for biotechnology and anticancer medications, the drug pipeline for these substances is anticipated to improve in the upcoming years. The Compound Management market is anticipated to be significantly affected by COVID 19.

Market Growth Factors

Growing Pharmaceutical And Biopharmaceutical Manufacturing

The pharmaceutical industry's fastest-growing subsegment is biopharmaceuticals. As the demand for sample management rises as a result of increased biologic production, the expansion of this industry will also aid that of the sample management market. Biologics demand is on the rise, biosimilars are developing, biopharmaceutical companies are spending more on research and development, and chronic diseases are on the rise. Additionally, by concentrating on outsourcing tasks to CROs and CMOs, the majority of biotech and biopharma businesses can concentrate on their core competencies.

Compound Management Helps Maintain Speed And Accuracy

inIn the sciences, accuracy and speed don't combine well. An effective compound management system must strike a balance between speed and accuracy because quick outcomes are frequently hurried, careless, or erroneous. Most compound handling systems aim to reduce human handling because it is the source of the vast majority of problems. Racks, carousels, and robotic arms are frequently used in automated compound backup and recovery systems to store and transfer compounds. The recommended method of storage is in a -20 °C dimethyl sulfoxide (DMSO) solution.

Market Restraining Factors

Compound Management Facilities Required Huge Investments

One or more people who oversee a chemical library at a research facility incur large costs for compound management regularly. For high-throughput screening and chemical genomics, it has emerged as a crucial technological element. The requirement for compound management presents significant problems, which are being overcome by coordinated efforts in both the public and private spheres. A compound/sample management facility requires significant financial outlays for both hardware and software, including the construction of new automated liquid compound storage systems connected to a substantial inventory database.

Type Outlook

Based on type, the compound management market is classified into Products (Automated Compound/Sample Storage Systems, Automated Liquid Handling Systems, and Other Compound/Sample Storage Systems) and services. The service segment witnessed a significant revenue share in the compound management market in 2021. It is due to the rise in drug development activities, the rising need for compound management services, and the growing desire to save costs associated with drug research are some of the key factors influencing the service segment's expansion.

Sample Type Outlook

On the basis of sample type, the compound management market is segmented into Chemical Compounds and Bio Samples. The bio sample segment witnessed a substantial revenue share in the compound management market in 2021. The industry is expanding due to the rising need for tailored treatments. Medical research requires access to essential biological material. The growth of cell-based research activities has resulted in a significant need for various biospecimens kept in biobanks.

Application Outlook

By application, the compound management market is divided into Drug Discovery, Gene Synthesis, Bio Banking and Others. The drug discovery segment garnered the highest revenue share in the compound management market in 2021. It is because to test a large number of chemicals with a biological target, high output screening is performed. The information on target activities is gathered from a large library. It is possible to find more active molecules through drug discovery. Thus, it is projected that an increase in drug discovery activity would lead to a significant increase in demand.

End-Use Outlook

Based on end-use, the compound management market is fragmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations and Others. The pharmaceutical companies segment garnered the highest revenue share in the compound management market in 2021. It is because more drugs are being discovered, that there is a raising need for chemicals, which is boosting the market's expansion. The market for compound management is divided into biopharmaceutical businesses, the pharmaceutical industry, contract research organizations (CROs), and others, which include governmental, academic, and research institutions, based on end-use.

Regional Outlook

Region-wise, the compound management market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region procured the largest revenue share in the compound management market in 2021. This is because the region is home to numerous pharmaceutical and biotechnology companies engaged in the drug discovery process. Consequently, there is a raising need for services in this area. A further factor driving this sector's growth is the increase in disease-related morbidity and mortality, which has led to the creation of more medication candidates. Positive drug discovery and research endeavors by public entities are further fostering regional market expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Beckman Coulter), Azenta US, Inc., Hamilton Company, BioAscent, Evotec SE, SPT Labtech Ltd., Tecan Group Ltd., Titian Software, LiCONiC AG, and AXXAM S.p.A.

Scope of the Study

Market Segments covered in the Report:

By Type

• Products

Automated Compound/Sample Storage Systems

Automated Liquid Handling Systems

Others

• Services

By Application

• Drug Discovery
• Gene Synthesis
• Bio Banking
• Others

By Sample Type

• Chemical Compounds
• Bio Samples

By End User

• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Research Organizations
• Others

By Geography

• North America

US

Canada

Mexico

Rest of North America

• Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

• Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

• LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

• Danaher Corporation (Beckman Coulter)
• Azenta US, Inc.
• Hamilton Company
• BioAscent
• Evotec SE
• SPT Labtech Ltd.
• Tecan Group Ltd.
• Titian Software
• LiCONiC AG
• AXXAM S.p.A.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free